These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 524316)

  • 21. Effects of clofibrate and 6-substituted chroman analogs on human platelet function: mechanism of inhibitory action.
    Huzoor-Akbar ; Patel S; Kokrady SS; Witiak DT; Newman HA; Feller DR
    Biochem Pharmacol; 1981 Jul; 30(14):2013-20. PubMed ID: 7271890
    [No Abstract]   [Full Text] [Related]  

  • 22. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of platelets and concanavalin A.
    Kaplan KL; Nachman RL
    Thromb Res; 1975 Dec; 7(6):847-59. PubMed ID: 1198553
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of hydroxyethyl starch on platelet aggregation in vitro.
    Blaicher AM; Reiter WJ; Blaicher W; Kettner SC; Felfernig M; Grabner CM; Zimpfer M
    Anesth Analg; 1998 Jun; 86(6):1318-21. PubMed ID: 9620527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of zomepirac on hemostasis in healthy adults and on platelet function in vitro.
    Mielke CH; Kahn SB; Muschek LD; Tighe JJ; Ng KT; Minn FL
    J Clin Pharmacol; 1980; 20(5-6 Pt 2):409-17. PubMed ID: 7400378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergism between collagen-adenosine diphosphate and collagen-epinephrine in platelets' aggregation: different dose response relationships.
    Razi MS; Hameed W; Habib SS; Aslam M; Ashraf R
    J Pak Med Assoc; 2009 Jun; 59(6):368-71. PubMed ID: 19534370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of nonresponsiveness to epinephrine in platelets from healthy humans.
    Choi JW
    Acta Haematol; 2002; 108(2):106-8. PubMed ID: 12187031
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet hypersensitivity induced by cholesterol incorporation.
    Shattil SJ; Anaya-Galindo R; Bennett J; Colman RW; Cooper RA
    J Clin Invest; 1975 Mar; 55(3):636-43. PubMed ID: 1117069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human platelet functions by verapamil.
    Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1981 Apr; 45(2):158-61. PubMed ID: 6789494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin: influence on hemostasis--a review.
    Mielke CH; Rodvien R
    Metabolism; 1978 Sep; 27(9 Suppl 1):1369-75. PubMed ID: 683004
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of lomustin on some platelet functions in vitro.
    Kubisz P; Parízek M; Touhami H; Brahimi S
    Neoplasma; 1987; 34(5):609-14. PubMed ID: 3696302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bicyclic thiophenic derivatives as platelet aggregation inhibitors.
    Darias V; Bravo L; Fraile C; Martin-Herrera D; Corral C; Lissavetzky J
    Farmaco Sci; 1986 Jun; 41(6):478-82. PubMed ID: 3743742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some effects of nicotine on platelets.
    Saba SR; Mason RG
    Thromb Res; 1975 Nov; 7(5):819-24. PubMed ID: 1209564
    [No Abstract]   [Full Text] [Related]  

  • 38. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
    Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
    Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet monoamine oxidase and epinephrine-induced platelet aggregation.
    Rossi EC; Louis G; Bieber M; Zeller EA
    Thromb Haemost; 1978 Aug; 40(1):37-42. PubMed ID: 725849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
    Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
    Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.